Modified Bacteriophage for Tumor Detection and Targeted Therapy.

Area of Science:

• Biotechnology
• Oncology
• Virology

Background:

• Malignant tumors are a major global health concern.
• Bacteriophages (phages) are bacterial viruses with potential biomedical applications.
• Genetic and chemical modifications enhance phage capabilities for cancer research.

Purpose of the Study:

• To review recent advancements in engineered and modified phages for tumor diagnosis and therapy.
• To explore the advantages and limitations of using modified phages in oncology.
• To suggest practical applications for modified phages in clinical settings.

Main Methods:

• Review of studies on genetically engineered phages for tumor antigen detection.
• Analysis of chemically modified phages for targeted cancer therapy.
• Investigation of phage-nanoparticle composites for enhanced biological detection and treatment.

Main Results:

• Engineered phages can serve as probes for detecting tumor-specific antigens.
• Modified phages demonstrate potential as anti-tumor therapeutic agents.
• Phage-nanoparticle conjugates expand applications in diagnostics and therapeutics.

Conclusions:

• Modified phages represent a versatile platform for cancer diagnosis and targeted therapy.
• Understanding the advantages and limitations is crucial for clinical translation.
• Specific application scenarios can be identified based on phage modification strategies.